StockNews.com Initiates Coverage on Akari Therapeutics (NASDAQ:AKTX)
Investment analysts at StockNews.com initiated coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Get Free Report) in a research note issued on Thursday. The firm set a “sell” rating on the biopharmaceutical company’s stock. Akari Therapeutics Stock Performance Shares of NASDAQ:AKTX opened at $2.79 on Thursday. The company has a fifty day simple moving average […]
More Stories
Financial Review: Knightscope (NASDAQ:KSCP) vs. VU1 (OTCMKTS:VUOC)
VU1 (OTCMKTS:VUOC – Get Free Report) and Knightscope (NASDAQ:KSCP – Get Free Report) are both consumer discretionary companies, but which...
Genus plc (OTCMKTS:GENSF) Short Interest Up 42.9% in October
Genus plc (OTCMKTS:GENSF – Get Free Report) saw a large increase in short interest during the month of October. As...
La Française des Jeux Société anonyme (OTCMKTS:LFDJF) Short Interest Up 50.7% in October
La Française des Jeux Société anonyme (OTCMKTS:LFDJF – Get Free Report) was the recipient of a large growth in short...
Short Interest in Renewi plc (OTCMKTS:SHMCF) Decreases By 20.0%
Renewi plc (OTCMKTS:SHMCF – Get Free Report) was the target of a large decrease in short interest in the month...
Impinj, Inc. (NASDAQ:PI) Short Interest Update
Impinj, Inc. (NASDAQ:PI – Get Free Report) was the recipient of a large decline in short interest in the month...
Short Interest in Packaging Co. of America (NYSE:PKG) Declines By 19.1%
Packaging Co. of America (NYSE:PKG – Get Free Report) was the target of a large drop in short interest during...